United Therapeutics (UTHR) Shares Issued (2009 - 2026)

United Therapeutics has disclosed Shares Issued across 18 years of filings, most recently posting $68.3 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $68.3 million, up 311.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.9 million (down 52.01% YoY), and the FY2025 annual result was $9.2 million, down 93.97% from the prior year.
• Shares Issued came in at $68.3 million for Q1 2026 at United Therapeutics, up from -$65.7 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $68.3 million in Q1 2026 to a low of -$65.7 million in Q4 2025.
• The 5-year median for Shares Issued is $24.3 million (2022), against an average of $23.2 million.
• Across the five-year window, Shares Issued jumped 1327.91% in 2023 and tumbled 355.64% in 2025, its largest moves.
• United Therapeutics' Shares Issued stood at $55.5 million in 2022, then plunged by 91.71% to $4.6 million in 2023, then soared by 458.7% to $25.7 million in 2024, then sank by 355.64% to -$65.7 million in 2025, then jumped by 203.96% to $68.3 million in 2026.
• The last three Shares Issued figures came in at $68.3 million (Q1 2026), -$65.7 million (Q4 2025), and $40.2 million (Q3 2025), per Business Quant data.